Rapid Micro Biosystems Inc. (RPID)
RPID trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/0001380106-26-000034-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | RPID on Nasdaq |
| Sector | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001380106 |
| SEC industry code | Laboratory Analytical Instruments |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $33.6M |
| Net income | -$47.1M |
| Operating income | -$47.4M |
| Net margin | -140.3% |
| Operating margin | -141.1% |
| Revenue growth | +19.7% |
| Cash | $20.0M |
| Total assets | $74.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-08-07 |
| Cash and burn | $14.7M cash; operating cash flow -$10.0M a quarter. | Report 2026-06-30 |
| Shares outstanding | 50,159,556 (2026-07-31); 44,210,328 a year earlier. | Cover page 2026-07-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the market | Latest 2026-05-19 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers LLP, Boston, Massachusetts, United States | PCAOB Form AP 2026-03-20 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $1.1M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $8.1M | -$12.9M | -$12.7M | $14.7M | $19.1M | $35.2M | 10-Q 2026-08-07 |
| Q1 2026 2026-03-31 | $8.0M | -$14.3M | -$15.1M | $13.8M | $19.1M | $34.4M | 10-Q 2026-05-15 |
| Q4 2025 2025-12-31 | $11.3M | -$12.5M | -$3.2M | $20.0M | $18.9M | $33.6M | 10-K 2026-03-12 |
| Q3 2025 2025-09-30 | $7.8M | -$11.5M | -$9.1M | $18.9M | $18.8M | $30.5M | 10-Q 2025-11-07 |
| Q2 2025 2025-06-30 | $7.3M | -$11.9M | -$9.7M | $18.3M | No debt tags | $30.3M | 10-Q 2026-08-07 |
| Q1 2025 2025-03-31 | $7.2M | -$11.3M | -$9.1M | $18.9M | No debt tags | $29.6M | 10-Q 2026-05-15 |
| Q4 2024 2024-12-31 | $8.2M | -$9.7M | -$9.9M | $16.9M | $0 | $28.1M | 10-K 2026-03-12 |
| Q3 2024 2024-09-30 | $7.6M | -$11.3M | -$8.6M | $22.0M | No debt tags | $26.2M | 10-Q 2025-11-07 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-05-19 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-08-07 |
| Latest current report | 8-K | 2026-11-16 |
| Latest proxy | DEFA14A | 2026-04-08 |
Source: SEC EDGAR submissions feed, 329 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +1.6% |
| 1 month | -25.5% |
| 3 months | -61.7% |
| Year to date | -77.6% |
| 1 year | -85.4% |
| From 52-week high | -86.1% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Laboratory Analytical Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PRPO | Precipio Inc. | $19.96 | -9.81% | $35.8M |
| EYPT | EyePoint Inc. | $0.3076 | +0.52% | $35.0M |
| HBIO | Harvard Bioscience Inc. | $8.91 | -5.96% | $40.7M |
| CIRC | Circle8 Group Inc. | $0.1702 | -7.30% | $20.0M |
| SEER | Seer Inc. | $1.48 | -5.73% | $82.6M |
| BNGO | Bionano Genomics Inc. | $0.9400 | -6.00% | $13.1M |
| QTRX | Quanterix Corporation | $2.84 | -3.07% | $134.8M |
| ASTC | Astrotech Corporation (DE) | $3.76 | -10.48% | $8.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier